CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis
about
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activationCD154: an immunoinflammatory mediator in systemic lupus erythematosus and rheumatoid arthritisThe pathology of multiple sclerosis and its evolutionSignal pathways in astrocytes activated by cross-talk between of astrocytes and mast cells through CD40-CD40LReduction of atherosclerosis in mice by inhibition of CD40 signallingLPS induces CD40 gene expression through the activation of NF-kappaB and STAT-1alpha in macrophages and microgliaThe microglial "activation" continuum: from innate to adaptive responsesTranslational utility of experimental autoimmune encephalomyelitis: recent developmentsThe Contribution of CD40/CD40L Axis in Inflammatory Bowel Disease: An UpdateRole of Tumor Necrosis Factor Superfamily in Neuroinflammation and AutoimmunityTargeting dendritic cell function during systemic autoimmunity to restore toleranceContribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosusNF-kappaB is involved in the regulation of CD154 (CD40 ligand) expression in primary human T cellsHuman genetics in rheumatoid arthritis guides a high-throughput drug screen of the CD40 signaling pathwayCD40 signaling of monocyte inflammatory cytokine synthesis through an ERK1/2-dependent pathway. A target of interleukin (il)-4 and il-10 anti-inflammatory actionAbsence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitisAnatomical and Cellular Requirements for the Activation and Migration of Virus-Specific CD8+ T Cells to the Brain during Theiler's Virus InfectionInhibition of CD40-TRAF6 interactions by the small molecule inhibitor 6877002 reduces neuroinflammation.CD40: novel association with Crohn's disease and replication in multiple sclerosis susceptibilityDeficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profileThe CD40-CD40L pathway contributes to the proinflammatory function of intestinal epithelial cells in inflammatory bowel disease.Activation of tolerogenic dendritic cells in the tumor draining lymph nodes by CD8+ T cells engineered to express CD40 ligand.Blocking costimulatory signals to induce transplantation tolerance and prevent autoimmune disease.CD40L and Its Receptors in Atherothrombosis-An UpdateMechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis.Acquired, but not innate, immune responses to Streptococcus pneumoniae are compromised by neutralization of CD40L.The CD40/CD40 ligand interaction is required for resistance to toxoplasmic encephalitis.Expression profiling of genes modulated by minocycline in a rat model of neuropathic painDevelopmental maturation of innate immune cell function correlates with susceptibility to central nervous system autoimmunity.Immune function of microglia.Preformed CD40L is stored in Th1, Th2, Th17, and T follicular helper cells as well as CD4+ 8- thymocytes and invariant NKT cells but not in Treg cells.Inflammation in the nervous system: the human perspective.CD154 blockade results in transient reduction in Theiler's murine encephalomyelitis virus-induced demyelinating disease.Association of SNPs of CD40 gene with multiple sclerosis in Russians.Normal Th1 development following long-term therapeutic blockade of CD154-CD40 in experimental autoimmune encephalomyelitis.T cell costimulatory pathways: blockade for autoimmunity.Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype.Modulation of dendritic cell immunobiology via inhibition of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase.The critical role of antigen-presentation-induced cytokine crosstalk in the central nervous system in multiple sclerosis and experimental autoimmune encephalomyelitis.Structure, size, and solubility of antigen arrays determines efficacy in experimental autoimmune encephalomyelitis.
P2860
Q21245246-E8D12F22-9553-40A4-B402-4AFA25F5453EQ21285053-F9620348-66AE-4231-8C01-3948C32DE973Q22242676-A55A5865-1963-4EBD-AC06-4DB8C4C46411Q24297472-DE7C79F8-7DE4-4619-9B83-9CC8EC9B0618Q24316540-20AAA30F-818B-4DDA-A8EB-C71303E061FCQ24685951-62AB6E98-9DA7-4CDE-AF74-8BAB5EED367EQ24814335-4C202EF8-0AB3-46DC-8706-0D99AD4EAABDQ26775820-B3107D5E-EA68-4C37-BC25-2171513917D1Q26777192-D8CBC013-5FE7-4384-8D52-E82F525F4FE4Q26800155-88C3A76B-46A6-455E-BFBC-DAC93BB6F8D4Q27687098-33D64EC3-3032-4D1B-A28A-2880484F3998Q28080920-2F6E3307-FEEE-41F6-83D0-B39C79FE03FEQ28347536-68BE1C43-17F6-4C2A-AF7A-CF7F74B4EF1AQ28488150-1F424C23-885B-4F1A-BEA3-7AD177D03289Q28609312-52E0BD21-B12B-49DC-8084-F295DE331F5CQ28755978-1FBF87F7-2F82-4C88-B9A2-A8D611A2BADCQ29013885-FAB0CC8E-3FBF-4262-8445-38BFB890DEEEQ30849102-C62E1470-16D4-464E-B0DB-43160F020D11Q33633981-AF59C9DE-CB7B-4679-836F-896D22FD788BQ33656103-71D23766-5818-49D2-BCA7-8231231B027FQ33745206-72524BB8-0AD4-4831-A9B0-03D8EBB31FFEQ33746583-992D3585-C808-47BB-AB4E-27941C7C1DFBQ33805849-00E8A0E9-3C62-4297-91C6-31FE1490FAEBQ33814059-4760B274-8250-4908-A2DF-32681127964CQ33835268-5E6E3898-18DB-44D2-9E46-4592E264428DQ34003178-34839AC7-F3B3-434F-A202-0C08532C2FFCQ34003535-AFCE60A4-3C1B-4385-BEC6-1EE6C23B97E9Q34039604-B332402C-005D-41B1-A442-247564B449E6Q34061505-29A43BB7-BDFB-43DE-ACC2-87E853B0F508Q34094707-0420DC37-B46C-42E7-9195-50D0B7B5A01FQ34170759-AD3BF98D-1D2C-4A90-9570-8DE7FFAC620FQ34398679-A4F9CF07-9B44-4043-9E02-1887DA09A201Q34466815-7EF7ECDF-7120-4804-9245-B47338434822Q34683951-67024D48-31F4-4BCB-B925-29FB8A8FC53AQ34787127-C7324A36-8DC3-418C-9FF3-59158BDC526DQ35093604-20637CC6-42A0-4AA0-A229-F7C144F8E840Q35161070-E7F24F99-F014-494F-B6EF-BE7D62866659Q35205220-836FE601-4EC8-4140-BF76-49CFC40B031DQ35294476-7193D1C3-C3EA-492F-A3CD-6D8206E82923Q35318199-C786F557-2BEC-4E0A-899B-77C37E0D6E53
P2860
CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CD40-CD40 ligand interactions ...... yelitis and multiple sclerosis
@en
CD40-CD40 ligand interactions ...... elitis and multiple sclerosis.
@nl
type
label
CD40-CD40 ligand interactions ...... yelitis and multiple sclerosis
@en
CD40-CD40 ligand interactions ...... elitis and multiple sclerosis.
@nl
prefLabel
CD40-CD40 ligand interactions ...... yelitis and multiple sclerosis
@en
CD40-CD40 ligand interactions ...... elitis and multiple sclerosis.
@nl
P2093
P2860
P356
P1476
CD40-CD40 ligand interactions ...... yelitis and multiple sclerosis
@en
P2093
E Claassen
J A Ledbetter
K Gerritse
R J Noelle
W J Boersma
P2860
P304
P356
10.1073/PNAS.93.6.2499
P407
P577
1996-03-01T00:00:00Z